oxatomide has been researched along with Dermatitis, Atopic in 7 studies
oxatomide: structure; an anti-allergic & an anti-asthmatic
oxatomide : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one substituted by a 3-[4-(diphenylmethyl)piperazin-1-yl]propyl group at position 1. It is an anti-allergic drug.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, compound 13d, having potent hydroxyl radical-scavenging activity, showed more potent suppressive effect on substance P-induced pruritus in mice than oxatomide." | 3.83 | Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases. ( Fujiwara, N; Hasegawa, F; Inoue, Y; Isobe, M; Isobe, Y; Tobe, M; Tsuboi, K, 2016) |
| "Oxatomide is an antiallergic molecule which acts mainly as a calcium blocker." | 3.76 | [Atopic dermatitis: role of oxatomide]. ( Taieb, A, 1990) |
| " The oral suspension was particularly easy to use in children less than two years old, on account of the simple dosage schedule." | 2.70 | Oxatomide in the treatment of atopic dermatitis in breast-fed and very young infants. ( Boccazzi, A; Cesuti, R; Pugni, L; Rapuzzi, S, 2001) |
| " A comparison between 2 different dosage schemes was scheduled." | 2.68 | [Treatment of atopic dermatitis with oxatomide oral suspension (2.5 mg/ml) in infants]. ( Bergonzi, F; Mangili, G, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tobe, M | 1 |
| Tsuboi, K | 1 |
| Hasegawa, F | 1 |
| Fujiwara, N | 1 |
| Inoue, Y | 1 |
| Isobe, M | 1 |
| Isobe, Y | 1 |
| Kimata, H | 2 |
| Hiratsuka, S | 1 |
| De Parades, V | 1 |
| Roulot, D | 1 |
| Neyrolles, N | 1 |
| Rautureau, J | 1 |
| Coste, T | 1 |
| Bergonzi, F | 1 |
| Mangili, G | 1 |
| Boccazzi, A | 1 |
| Pugni, L | 1 |
| Cesuti, R | 1 |
| Rapuzzi, S | 1 |
| Taieb, A | 1 |
1 review available for oxatomide and Dermatitis, Atopic
| Article | Year |
|---|---|
[Atopic dermatitis: role of oxatomide].
Topics: Dermatitis, Atopic; Histamine H1 Antagonists; Humans; Immunoglobulin E; Piperazines | 1990 |
4 trials available for oxatomide and Dermatitis, Atopic
| Article | Year |
|---|---|
Effect of topical cromoglycate solution on atopic dermatitis: combined treatment of sodium cromoglycate solution with the oral anti-allergic medication, oxatomide.
Topics: Administration, Oral; Administration, Topical; Adolescent; Child; Child, Preschool; Cromolyn Sodium; | 1994 |
[Treatment of atopic dermatitis with oxatomide oral suspension (2.5 mg/ml) in infants].
Topics: Administration, Oral; Anti-Allergic Agents; Child, Preschool; Dermatitis, Atopic; Dose-Response Rela | 1997 |
Oxatomide in the treatment of atopic dermatitis in breast-fed and very young infants.
Topics: Anti-Allergic Agents; Breast Feeding; Child, Preschool; Dermatitis, Atopic; Female; Humans; Infant; | 2001 |
[Atopic dermatitis: role of oxatomide].
Topics: Dermatitis, Atopic; Histamine H1 Antagonists; Humans; Immunoglobulin E; Piperazines | 1990 |
3 other studies available for oxatomide and Dermatitis, Atopic
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Benzofurans; Cell Line, Tumor; Cell Membran | 2016 |
Enhancement of allergic skin wheal responses in patients with atopic eczema/dermatitis syndrome by playing video games or by a frequently ringing mobile phone.
Topics: Adult; Allergens; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Azulenes; Cell Phon | 2003 |
[Acute cytolytic hepatitis during administration of oxatomide].
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Dermatitis, Atopic; Histamine H1 Antag | 1994 |